Large gap with delayed quotes
|
Last quote
06/18/2026
-
02:00:00
|
Bid
06/17/2026 -
21:59:58
|
Bid Volume |
Ask
06/17/2026 -
21:59:58
|
Ask Volume |
|---|---|---|---|---|
|
16.71
+0.73
(
+4.57% )
|
16.69
|
400 |
16.71
|
2,800 |
Analysis date: 16.06.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 22.05.2026.
Interest
Very weak
Very weak
One star since 05.06.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 02.06.2026 at a price of 15.87.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 06.02.2026.
4wk Rel Perf
-6.38%
-6.38%
The four-week dividend-adjusted underperformance versus SP500 is 6.38%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 15.07.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.78%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 6.13%.
Mkt Cap in $bn
1.80
1.80
With a market capitalization <$2bn, VIRIDIAN THERAPEUTICS is considered a small-cap stock.
G/PE Ratio
0.17
0.17
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
-271.66
-271.66
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
46.06%
46.06%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
13
13
Over the last seven weeks, an average of 13 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
-2
-2
For 1% of index variation, the stock varies on average by -0.02%.
Correlation
-0.01
-0.01
Stock movements are strongly independent of index variations, with an even divergent trend.
Value at Risk
8.42
8.42
The value at risk is estimated at USD 8.42. The risk is therefore 52.70%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
15.07.2025
15.07.2025